India's Shilpa Medicare rises as unit inks biologics deal with mAbTree Biologics
18/03/2025 04:05
** Shares of Shilpa Medicare SHME.NS rise 2.4% at 645 rupees ** SHME on Monday says its unit enters into deal with Switzerland-based mAbTree Biologics for development, manufacture, marketing and sale of a new biological entity ** Stock set to gain for a second session straight ** SHME shares down ~23% so far this year; pharma index .NIPHARM down ~11% (Reporting by Yagnoseni Das in Bengaluru) ((Yagnoseni.Das@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026